Patents by Inventor Eli Moallem

Eli Moallem has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adenylyl cyclase-associated protein (CAP1) and uses thereof as a target for immuno-modulation
    Patent number: 8642041
    Abstract: The present invention relates to the use of Adenylyl Cyclase-Associated Protein (CAP1) as a target for immuno-modulation. More specifically, the invention relates to the use of compounds that interact and bind CAP1, specifically, anti-CAP1 antibodies, and/or to CAP1 molecule or any fragments thereof, for the treatment of immune-related disorders by modulation of the Th1/Th2 balance. The invention further provides screening method for immuno-modulatory compounds that interact with CAP1.
    Type: Grant
    Filed: March 21, 2010
    Date of Patent: February 4, 2014
    Assignee: Protab Ltd.
    Inventors: Yaakov Naparstek, Eli Moallem
  • ADENYLYL CYCLASE-ASSOCIATED PROTEIN (CAP1) AND USES THEREOF AS A TARGET FOR IMMUNO-MODULATION
    Publication number: 20120014973
    Abstract: The present invention relates to the use of Adenylyl Cyclase-Associated Protein (CAP1) as a target for immuno-modulation. More specifically, the invention relates to the use of compounds that interact and bind CAP1, specifically, anti-CAP1 antibodies, and/or to CAP1 molecule or any fragments thereof, for the treatment of immune-related disorders by modulation of the Th1/Th2 balance. The invention further provides screening method for immuno-modulatory compounds that interact with CAP1.
    Type: Application
    Filed: March 21, 2010
    Publication date: January 19, 2012
    Applicant: PROTAB LTD.
    Inventors: Yaakov Naparstek, Eli Moallem